Scholarlink

Background <p>Frailty is increasingly recognized as an important morbidity among people living with HIV (PLHIV). However, no published data exist on its prevalence or determinants in Kazakhstan or Central Asia. This pilot study aimed to provide preliminary estimates of frailty prevalence and its associated factors among PLHIV in Almaty, Kazakhstan.</p> Methods <p>We conducted a cross-sectional pilot study at the Almaty Centre for AIDS Prevention and Control. A total of 100 PLHIV aged 40 years and older were recruited during routine clinical visits from a previous pilot study on cardiovascular health. Frailty was assessed via the Fried frailty Phenotype that included slow gait speed, weak grip strength, exhaustion, low physical activity, and unintentional weight loss. Participants meeting three or more criteria were classified as frail, and those meeting two or more criteria were classified as prefrail/frail. Logistic regression models were used to examine associations of prefrailty/frailty with HIV-related factors, multimorbidity (≥ 3 chronic conditions other than HIV), depressive symptoms, HIV-related stigmas, and expectations regarding aging.</p> Results <p>The participants had a mean age of 50 years (SD 7.9), and 58% were male. The prevalence of frailty was 13%, whereas 40% met the criteria for prefrailty/frailty. Multimorbidity (adjusted odds ratio [AOR] 3.44, 95% confidence interval [CI] 1.40–8.79), depressive symptoms (AOR 1.09, 95% CI 1.02–1.19), internalized HIV-related stigma (AOR 1.25, 95% CI 1.05–1.56), and clinic-based HIV stigma (AOR 1.57, 95% CI 1.18–2.10) were associated with greater odds of prefrailty/frailty. Neurological, endocrine/metabolic, and noninfectious respiratory conditions were also significantly associated with the outcome. HIV-specific indicators such as the CD4 count and viral load were not significantly associated.</p> Conclusions <p>Frailty is present among middle-aged and older PLHIV in Kazakhstan. Psychosocial factors and multimorbidity were more strongly associated with frailty than were HIV-specific indicators. As a pilot study with a modest sample size, these findings should be interpreted as preliminary but emphasize the need for larger-scale studies and interventions addressing frailty among PLHIV in the region.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Exploring frailty in the context of HIV and aging in Kazakhstan: findings from a pilot cross-sectional study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月7日

查看全文
  • Balnur Iskakova,
  • Deborah Gustafson,
  • Aigerim Alimbekova,
  • Nursultan Nurzhigitov,
  • Anarkhan Nurkerimova,
  • Gulmira Kalzhanbayeva,
  • Gulnara Nugumanova,
  • Ademi Sarsembiyeva,
  • Jack DeHovitz,
  • Zhamilya Nugmanova

摘要

Background

Frailty is increasingly recognized as an important morbidity among people living with HIV (PLHIV). However, no published data exist on its prevalence or determinants in Kazakhstan or Central Asia. This pilot study aimed to provide preliminary estimates of frailty prevalence and its associated factors among PLHIV in Almaty, Kazakhstan.

Methods

We conducted a cross-sectional pilot study at the Almaty Centre for AIDS Prevention and Control. A total of 100 PLHIV aged 40 years and older were recruited during routine clinical visits from a previous pilot study on cardiovascular health. Frailty was assessed via the Fried frailty Phenotype that included slow gait speed, weak grip strength, exhaustion, low physical activity, and unintentional weight loss. Participants meeting three or more criteria were classified as frail, and those meeting two or more criteria were classified as prefrail/frail. Logistic regression models were used to examine associations of prefrailty/frailty with HIV-related factors, multimorbidity (≥ 3 chronic conditions other than HIV), depressive symptoms, HIV-related stigmas, and expectations regarding aging.

Results

The participants had a mean age of 50 years (SD 7.9), and 58% were male. The prevalence of frailty was 13%, whereas 40% met the criteria for prefrailty/frailty. Multimorbidity (adjusted odds ratio [AOR] 3.44, 95% confidence interval [CI] 1.40–8.79), depressive symptoms (AOR 1.09, 95% CI 1.02–1.19), internalized HIV-related stigma (AOR 1.25, 95% CI 1.05–1.56), and clinic-based HIV stigma (AOR 1.57, 95% CI 1.18–2.10) were associated with greater odds of prefrailty/frailty. Neurological, endocrine/metabolic, and noninfectious respiratory conditions were also significantly associated with the outcome. HIV-specific indicators such as the CD4 count and viral load were not significantly associated.

Conclusions

Frailty is present among middle-aged and older PLHIV in Kazakhstan. Psychosocial factors and multimorbidity were more strongly associated with frailty than were HIV-specific indicators. As a pilot study with a modest sample size, these findings should be interpreted as preliminary but emphasize the need for larger-scale studies and interventions addressing frailty among PLHIV in the region.